1. Home
  2. Stocks
  3. Jlhl Share Price

Jupiter Life Line Hospitals Share Price

Healthcare Mid Cap

₹1,372.75 -5.45 (-0.4%)

05 Nov, 2024 21:58

SIP TrendupStart SIP in JLHL

Start SIP
Performance Financial Technical Events FnO Shareholding Pattern More FAQ’s

Performance

  • Low
  • ₹1,360
  • High
  • ₹1,391
  • 52 Week Low
  • ₹993
  • 52 Week High
  • ₹1,654
  • Open Price₹1,368
  • Previous Close₹1,378
  • Volume84,405

Investment Returns

  • Over 1 Month -4.16%
  • Over 3 Month + 1.87%
  • Over 6 Month + 12.19%
  • Over 1 Year + 34.83%
SIP Lightning

Smart Investing Starts Here Start SIP with Jupiter Life Line Hospitals for Steady Growth!

Jupiter Life Line Hospitals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 53.8
  • PEG Ratio
  • 0.7
  • Market Cap Cr
  • 9,001
  • P/B Ratio
  • 7.7
  • Average True Range
  • 45.05
  • EPS
  • 23.2
  • Dividend Yield
  • 0.1
  • MACD Signal
  • -3.54
  • RSI
  • 53.25
  • MFI
  • 92.44

Jupiter Life Line Hospitals Financial

IndicatorJun 24Mar 24Dec 23Sep 23Jun 23
Net Sales/Income from operations239.41245.31230.38227.07207.87
Total Income From Operations239.41245.31230.38227.07207.87
P/L Before Interest, Excpt. Items & Tax55.9457.6657.3257.3250.17
P/L Before Exceptional Items & Tax54.9956.7356.3148.8141.97
P/L After Tax from Ordinary Activities40.6543.1542.2436.1330.44
Net Profit/Loss For the Period40.6543.1542.2436.1330.44
IndicatorMar 24Mar 23
Revenue From Operations [Gross]910.63787.32
Revenue From Operations [Net]910.63787.32
Total Operating Revenues910.63787.32
Total Revenue940.26800.62
Total Expenses736.44639.61
Profit/Loss Before Tax203.82158.88
Profit/Loss For The Period151.95107.21
IndicatorMar 24Mar 23
Net CashFlow - Operating Activity109.79184.03
Net Cash Used In Investing Activity-256.48-129.66
Net Cash Used in Finance Activity310.58-23.22
Net Inc/Dec In Cash And Equivalent163.8931.15
Cash And Equivalent End Of Year297.20133.31
IndicatorMar 24Mar 23
Total Share Capital65.5756.52
Total Non-Current Liabilities27.04319.69
Total Current Liabilities88.30100.62
Total Capital And Liabilities1,360.60885.34
Total Non-Current Assets976.88688.50
Total Current Assets383.72196.84
Total Assets1,360.60885.34
Indicator20242023
EBIT Margin (%)24.4323.96
Return On Capital Employed (%)17.4824.04
Return On Equity (%)12.2023.05
Long Term Debt To Equity (%)0.0063.37
Book Value/Share (INR)189.9282.28
IndicatorJun 24Mar 24Dec 23Sep 23Jun 23
Net Sales/Income from operations287.13290.49272.61263.18243.22
Total Income From Operations287.13290.49272.61263.18243.22
P/L Before Interest, Excpt. Items & Tax61.2260.8459.2654.3747.28
P/L Before Exceptional Items & Tax60.1459.9258.2442.1435.12
P/L After Tax from Ordinary Activities44.6145.2743.6733.6854.00
Net Profit/Loss For the Period44.6145.2743.6733.6854.00
IndicatorMar 24Mar 23
Revenue From Operations [Gross]1,069.50892.54
Revenue From Operations [Net]1,069.50892.54
Total Operating Revenues1,069.50892.54
Total Revenue1,095.48902.96
Total Expenses900.07772.05
Profit/Loss Before Tax195.42128.71
Profit/Loss For The Period176.6172.91
IndicatorMar 24Mar 23
Net CashFlow - Operating Activity114.52176.40
Net Cash Used In Investing Activity-75.89-94.25
Net Cash Used in Finance Activity128.16-51.06
Net Inc/Dec In Cash And Equivalent166.7931.10
Cash And Equivalent End Of Year301.25134.46
IndicatorMar 24Mar 23
Total Share Capital65.5756.52
Total Non-Current Liabilities6.84489.49
Total Current Liabilities105.75132.14
Total Capital And Liabilities1,281.33985.53
Total Non-Current Assets871.57776.27
Total Current Assets409.77209.26
Total Assets1,281.33985.53
Indicator20242023
EBIT Margin (%)20.7319.40
Return On Capital Employed (%)18.8620.29
Return On Equity (%)15.1019.93
Long Term Debt To Equity (%)0.00123.74
Book Value/Share (INR)178.2564.39

Jupiter Life Line Hospitals Technicals

EMA & SMA

Current Price
₹1,372.75
-5.45 (-0.4%)
pointer
  • stock-down_img
  • Bullish Moving Average 16
  • stock-up_img
  • Bearish Moving Average 0
  • 20 Day
  • ₹1,361.04
  • 50 Day
  • ₹1,355.53
  • 100 Day
  • ₹1,328.82
  • 200 Day
  • ₹1,268.78

Resistance and Support

1374.53 Pivot Speed
  • R3 1,419.92
  • R2 1,405.38
  • R1 1,389.07
  • S1 1,358.22
  • S2 1,343.68
  • S3 1,327.37

Is Jupiter Life Line Hospitals Worth Buying?

BUY SELL HOLD

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Jupiter Life Line Hospitals is a leading healthcare provider in India, offering a wide range of medical services, including multi-specialty care, advanced diagnostics, and emergency services. The hospital focuses on patient-centric care and innovative treatment solutions. Jupiter Life Line Hospitals Ltd has an operating revenue of Rs. 1,113.40 Cr. on a trailing 12-month basis. An annual revenue growth of 21% is outstanding, Pre-tax margin of 18% is great, ROE of 15% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 50DMA and around 5% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 4% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 91 which is a GREAT score indicating consistency in earnings, a RS Rating of 58 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 50 indicates it belongs to a fair industry group of Medical-Hospitals and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail. Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation. (+)

Jupiter Life Line Hospitals Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-08 Quarterly Results
2024-08-09 Quarterly Results
2024-05-10 Audited Results & Dividend
2024-02-09 Quarterly Results
2023-11-10 Quarterly Results
Date Purpose Remarks
2024-08-02 FINAL Rs.1.00 per share(10%)Final Dividend

Jupiter Life Line Hospitals F&O

Jupiter Life Line Hospitals Shareholding Pattern

40.91%
12.34%
0.91%
8.84%
24.38%
12.62%
  • NSE Symbol
  • JLHL
  • BSE Symbol
  • 543980
  • Chairman & Managing Director
  • Dr. Ajay Pratap Thakker
  • ISIN
  • INE682M01012

Jupiter Life Line Hospitals FAQs

Jupiter Life Line Hospitals share price is ₹1,372 As on 05 November, 2024 | 21:44

The Market Cap of Jupiter Life Line Hospitals is ₹9000.6 Cr As on 05 November, 2024 | 21:44

The P/E ratio of Jupiter Life Line Hospitals is 53.8 As on 05 November, 2024 | 21:44

The PB ratio of Jupiter Life Line Hospitals is 7.7 As on 05 November, 2024 | 21:44

Q2FY23
Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form

The Vigilance Awareness Week for the year 2024 (VAW 2024) would be observed from October 28, 2024 to November 03, 2024
“सत्यनिष्ठा की संस्कृनि सेराष्र की समद्ृधि” “Culture of Integrity for Nation's Prosperity”
e-pledge link (https://pledge.cvc.nic.in/)

5paisa Capital Ltd. CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI-registered Mutual Fund Distributor | AMFI REGN No.: ARN-104096 | Date of initial Registration: 30/07/2015 | Current validity of ARN : 30/07/2027 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

*Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of ₹10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

Contact Us

Attention Investors

  • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
  • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
  • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

Email: support@5paisa.com

Support Desk Helpline: 8976689766

©2024, 5paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.